首页> 外文期刊>European journal of human genetics: EJHG >Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome
【24h】

Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome

机译:MED13L中的新型从头杂合功能丧失变异体和MED13L单倍功能不全综合征的进一步描述

获取原文
获取原文并翻译 | 示例
       

摘要

MED13L haploinsufficiency has recently been described as responsible for syndromic intellectual disability. We planned a search for causative gene variants in seven subjects with intellectual disability and overlapping dysmorphic facial features such as bulbous nasal tip, short mouth and straight eyebrows. We found two de novo frameshift variants in MED13L, consisting in single-nucleotide deletion (c.3765delC) and duplication (c.607dupT). A de novo nonsense variant (c.4420A4T) in MED13L was detected in a further subject in the course of routine whole-exome sequencing. By analyzing the clinical data of our patients along with those recently described in the literature, we confirm that there is a common, recognizable phenotype associated with MED13L haploinsufficiency, which includes intellectual disability and a distinctive facial appearance. Congenital heart diseases are found in some subjects with various degree of severity. Our observation of cleft palate, ataxia, epilepsy and childhood leukemia observed in single cases broadens the known clinical spectrum. Haploinsufficiency for MED13L should be considered in the differential diagnosis of the 1p36 microdeletion syndrome, due to overlapping dysmorphic facial features in some patients. The introduction of massive parallel-sequencing techniques into clinical practice is expected to allow for detection of other causative point variants in MED13L. Analysis of genomic data in connection with deep clinical evaluation of patients could elucidate genetic heterogeneity of the MED13L haploinsufficiency phenotype.
机译:MED13L单倍剂量不足最近被描述为综合征性智力障碍。我们计划在7名具有智力障碍和重叠畸形的面部特征(例如球根鼻尖,短嘴和直眉)的受试者中寻找致病性基因变异。我们在MED13L中发现了两个从头开始的移码变体,包括单核苷酸缺失(c.3765delC)和重复(c.607dupT)。在常规全外显子组测序过程中的另一位受试者中检测到MED13L中的从头无意义变体(c.4420A4T)。通过分析我们患者的临床数据以及最近在文献中描述的数据,我们确认存在与MED13L单倍功能不全相关的常见,可识别的表型,其中包括智障和独特的面部外观。先天性心脏病在一些严重程度不同的受试者中被发现。我们在单个病例中观察到的left裂,共济失调,癫痫和儿童白血病的观察扩大了已知的临床范围。在1p36微缺失综合征的鉴别诊断中,应考虑MED13L的单倍剂量不足,因为某些患者的面部特征重叠重叠。预计将大量的并行测序技术引入临床实践可以检测MED13L中的其他致病点变异。基因组数据的分析以及对患者的深入临床评估可以阐明MED13L单倍功能不足表型的遗传异质性。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号